KELSEY ANN COLE
Allopathic & Osteopathic Physicians|Family Medicine FORT SMITH, AR NPI 1013778612
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AR Acerta Pharma LLC All categories
General Payments — all program years on this page
$774.03
- Category: General Payments
- Program years: PY2024
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $774.03 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $774.03 | 43 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $101.54 | 6 |
| Daiichi Sankyo Inc. | $79.40 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $75.48 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $70.42 | 4 |
| Janssen Biotech, Inc. | $57.55 | 4 |
| EISAI INC. | $47.21 | 2 |
| PFIZER INC. | $45.01 | 2 |
| Rigel Pharmaceuticals, Inc. | $40.25 | 2 |
| Merck Sharp & Dohme Corporation | $35.63 | 2 |
| Lilly USA, LLC | $34.57 | 2 |
| Pharmacosmos Therapeutics Inc. | $28.91 | 2 |
| SERVIER PHARMACEUTICALS LLC | $19.13 | 1 |
| Stemline Therapeutics Inc. | $17.99 | 1 |
| GENZYME CORPORATION | $17.97 | 1 |
| Exelixis Inc. | $16.75 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.55 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.88 | 1 |
| Ipsen Biopharmaceuticals, Inc | $14.22 | 1 |
| PharmaEssentia USA Corporation | $14.13 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.09 | 1 |
| JAZZ PHARMACEUTICALS INC. | $13.35 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $774.03 | 43 |
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.